Cromos Pharma, where the patients are

Drug Sponsors

Gene by Gene acquires Arpeggi

Wednesday, August 7, 2013 02:18 PM

Gene by Gene, which develops consumer DNA testing products for ancestry and genealogy applications, has acquired Arpeggi, a developer of solutions for genome sequencing, data management and computational analysis.

More... »

CRF Health eCOA webinar series

The Medicines Company completes Profibrix acquisition on positive trial results

Wednesday, August 7, 2013 11:53 AM

The Medicines Company announced the results of a phase III clinical trial of ProFibrix's lead biologic, Fibrocaps, and, based on its review of those results, completed its previously announced purchase of the company.

More... »


Komtur Pharmaceuticals forms joint venture with HenHeKangJain China

Wednesday, August 7, 2013 11:38 AM

Komtur Pharmaceuticals, a German specialist in clinical trial sourcing, is investing in Chinese HengHeKangJian Pharmaceutical Trading. The joint venture company will operate under Komtur-Solin Pharmaceuticals.

More... »

NuMe Health becomes MicroBiome Therapeutics

Wednesday, August 7, 2013 11:36 AM

NuMe Health has changed its name to MicroBiome Therapeutics and has hired Steve Orndorff, Ph.D., as chief executive officer.

More... »

SAGE Therapeutics awarded NIH grant for Fragile X Syndrome

Thursday, August 1, 2013 10:30 AM

The NIH has granted SAGE Therapeutics, a neuroscience product-focused company creating novel medicines to treat central nervous system (CNS) disorders, an award potentially worth up to $10 million to support the company's development of a novel drug which could be used to treat anxiety and social deficits in patients with Fragile X Syndrome (FXS).

More... »

Actelion to acquire Ceptaris

Thursday, August 1, 2013 10:00 AM

San Francisco, Calif.-based pharmaceutical company Actelion will acquire Ceptaris Therapeutics, contingent upon certain closing conditions, including FDA approval of Ceptaris' product, VALCHLOR.

More... »

Cubist to acquire Optimer, Trius

Wednesday, July 31, 2013 11:43 AM

Cubist Pharmaceuticals has signed agreements to acquire both Optimer Pharmaceuticals and Trius Therapeutics. Both transactions have been approved by company boards of directors and are expected to close later this year, subject to stockholder approval.

More... »

Pfizer to create separate internal, global innovative and value businesses

Monday, July 29, 2013 03:00 PM

Pfizer has announced plans to internally separate its commercial operations into three business segments, two of which will include innovative business lines and a third to include the value business line. 

More... »

PSI expands South African clinical trial presence

Monday, July 29, 2013 01:29 PM

Switzerland-based CRO PSI has expanded into South Africa and will expand its access to all African countries from its base in Pretoria. PSI's experience in South Africa includes oncology, CNS, urology and diabetes.

More... »

Perrigo to acquire Elan for $8.6 billion

Monday, July 29, 2013 11:02 AM

Allegan, Mich.-based Perrigo, a global provider of healthcare products and Elan, a Dublin-based biotechnology company, have entered into a definitive agreement under which Elan will be acquired by a new holding company incorporated in Ireland (“New Perrigo”).

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs